Placental Growth Factor for the Prediction of Adverse Outcomes in Patients with Suspected Preeclampsia or Intrauterine Growth Restriction

Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia

(2012) Sarosh Rana et al.   CIRCULATION

Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia

(2012) Tinnakorn Chaiworapongsa et al.   Journal of Maternal-Fetal & Neonatal Medicine

A longitudinal study of plasma levels of soluble fms-like tyrosine kinase 1 (sFlt1), placental growth factor (PlGF), sFlt1: PlGF ratio and vascular endothelial growth factor (VEGF-A) in normal pregnancy

(2011) MARIA PALM et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

Evaluation and management of severe preeclampsia before 34 weeks' gestation

(2011) Baha M. Sibai   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Benefits and risks of expectant management of severe preeclampsia at less than 26 weeks gestation: the impact of gestational age and severe fetal growth restriction

(2011) Jérémi Belghiti et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Midgestation Maternal Serum 25-Hydroxyvitamin D Level and Soluble Fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio as Predictors of Severe Preeclampsia

(2011) Padmashree Chaudhury Woodham et al.   HYPERTENSION

Prospective Study of Placental Angiogenic Factors and Maternal Vascular Function Before and After Preeclampsia and Gestational Hypertension

(2010) Muna Noori et al.   CIRCULATION

Evidence-based Approach to Umbilical Artery Doppler Fetal Surveillance in High-risk Pregnancies: An Update

(2010) DEV MAULIK et al.   CLINICAL OBSTETRICS AND GYNECOLOGY

The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome

(2010) Brett Young et al.   Journal of Maternal-Fetal & Neonatal Medicine

Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model

(2010) Peter von Dadelszen et al.   LANCET

Maternal serum placental growth factor and soluble fms-like tyrosine kinase 1 as early predictors of preeclampsia

(2009) Mahmoud Shokry et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review

(2009) Shakila Thangaratinam et al.   BMC Medicine

Serum sFlt1:PlGF Ratio, PlGF, and Soluble Endoglin Levels in Gestational Proteinuria

(2009) Akihide Ohkuchi et al.   HYPERTENSION IN PREGNANCY

A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia

(2009) Juan Pedro Kusanovic et al.   Journal of Maternal-Fetal & Neonatal Medicine

Expectant Management in Pregnancies with Severe Pre-eclampsia

(2009) Bassam Haddad et al.   SEMINARS IN PERINATOLOGY

The Global Impact of Pre-eclampsia and Eclampsia

(2009) Lelia Duley   SEMINARS IN PERINATOLOGY

Secular Trends in the Rates of Preeclampsia, Eclampsia, and Gestational Hypertension, United States, 1987-2004

(2008) A. B. Wallis et al.   AMERICAN JOURNAL OF HYPERTENSION

The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age

(2008) Offer Erez et al.   Journal of Maternal-Fetal & Neonatal Medicine

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate

(2008) Roberto Romero et al.   Journal of Maternal-Fetal & Neonatal Medicine